AAAAAA

   
Results: 1-2 |
Results: 2
ABARELIX (PPI-149), A NOVEL AND POTENT GNRH ANTAGONIST, INDUCES A RAPID AND PROFOUND REDUCTION IN PROSTATE-GLAND VOLUME (PGV) AND ANDROGEN LEVELS BEFORE BRACHYTHERAPY (BT) OR RADIATION-THERAPY (XRT)
Authors: GARNICK MB GITTELMAN M STEIDEL C CENTENO A KLIMBERG I BROSMAN S MCMURRAY J WIATRAK M TUTTLE J WHITMORE W KUCA B LAVIN P
Citation: Mb. Garnick et al., ABARELIX (PPI-149), A NOVEL AND POTENT GNRH ANTAGONIST, INDUCES A RAPID AND PROFOUND REDUCTION IN PROSTATE-GLAND VOLUME (PGV) AND ANDROGEN LEVELS BEFORE BRACHYTHERAPY (BT) OR RADIATION-THERAPY (XRT), The Journal of urology, 159(5), 1998, pp. 850-850
DOXAZOSIN FOR BENIGN PROSTATIC HYPERPLASIA - LONG-TERM EFFICACY AND SAFETY IN HYPERTENSIVE AND NORMOTENSIVE PATIENTS
Authors: LEPOR H KAPLAN SA KLIMBERG I MOBLEY DF FAWZY A GAFFNEY M ICE K DIAS N
Citation: H. Lepor et al., DOXAZOSIN FOR BENIGN PROSTATIC HYPERPLASIA - LONG-TERM EFFICACY AND SAFETY IN HYPERTENSIVE AND NORMOTENSIVE PATIENTS, The Journal of urology, 157(2), 1997, pp. 525-530
Risultati: 1-2 |